IL6 and benign prostatic hyperplasia: Astonishingly, EX effectively alleviated the IL-6 level from 2.4 ± 0.4 pg/mL down to 0.68 ± 0.06 pg/mL in group BPH + DM (p < 0.01) (Fig. 10).